DETROIT, Jan. 19, 2017 /PRNewswire-USNewswire/ -- Lisa Lange, ANP-BC, AOCN, of the Barbara Ann Karmanos Cancer Institute, has been promoted to vice president of the Clinical Trials Office (CTO), effective immediately. Lange brings 26 years of experience as a nurse and nurse practitioner, specialized in clinical oncology care and research. She has been with Karmanos for 19 years, increasing her managerial and administration responsibilities during her tenure.
In her new position, Lange is responsible for coordinating, facilitating and reporting on clinical trials throughout Karmanos Cancer Institute's system-wide network. Her responsibilities complement the Protocol Review and Monitoring System, and ensures the validity and accuracy of the centralized database for tracking and reporting, as well as ensuring quality control. Lange has overall administrative responsibility and oversight for the daily operations, managing more than 140 full-time clinical research personnel. She reports directly to the associate center director of Clinical Sciences and works closely with physician senior leadership to ensure study compliance, education and centralized training for researchers and staff members.
"Lisa's clinical and research expertise, analytic and problem-solving skills, as well as her kind and calm approach with patients and staff, make her an excellent choice for vice president of our Clinical Trials Office," said Gerold Bepler, M.D., Ph.D., president and CEO, Karmanos Cancer Institute. "Her leadership experience has contributed to making our CTO one of the largest in the country, with a higher patient accrual. Working with our medical team, clinical trials participation will continue to be enhanced system-wide, giving cancer patients throughout the state of Michigan better access to innovative treatments often not available elsewhere."
Prior to her promotion to VP, Lange served as the interim director of the CTO since May 2016, and as director of the Eisenberg Center for Translational Therapeutics (Phase l) for two years prior. In these positions, she fulfilled the Clinical Protocol and Data Management functions for the Core Center Support Grant that helped secure Karmanos' National Cancer Institute designation as a comprehensive cancer center, an honored distinction that Karmanos has held since 1978. Lange worked extensively in Phase l since 2003.
"I'm honored to work with the exceptional team of professionals at Karmanos, as well as the inspiring patients we see every day," said Lange. "Not only do they understand the importance of clinical trials, they realize that by their participation they are helping to advance new cancer therapies that could potentially be the next standard of cancer care."
Lange received her Bachelor of Science in Nursing in 1989 and her Masters in Nursing in 1998, both from Wayne State University. In addition, she received a certificate in the Psychology of Aging and Well Being in 2016; and she also holds certifications as an Adult Nurse Practitioner and Advanced Oncology Certified Nurse.
About the Barbara Ann Karmanos Cancer Institute
Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute, a subsidiary of McLaren Health Care, is one of 47 National Cancer Institute-designated comprehensive cancer centers in the United States. Karmanos is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteer and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. Its long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. Gerold Bepler, M.D., Ph.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to www.karmanos.org.
SOURCE Barbara Ann Karmanos Cancer Institute
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article